TrimRx's Blog
NASH and GLP-1 Medications: Can They Reverse Liver Damage
NASH, or nonalcoholic steatohepatitis, is one of the few serious progressive liver conditions where a medication taken for a different primary purpose, weight loss,…
Tirzepatide and Fatty Liver Disease: What the Research Shows
Tirzepatide reduces liver fat, and the evidence is building quickly. For patients with nonalcoholic fatty liver disease (NAFLD) or its more advanced form, nonalcoholic…
PCOS and Tirzepatide: Is Mounjaro Better Than Ozempic for PCOS?
For women with PCOS, the choice between tirzepatide and semaglutide isn’t just about which medication produces more weight loss. It’s about which one addresses…
Tirzepatide for Metabolic Syndrome: Why the Dual Mechanism Matters
Metabolic syndrome is one of the most common and underdiagnosed conditions in adults, and tirzepatide addresses nearly every component of it simultaneously. If you…
GLP-1 Medications and Cholesterol: What to Expect in Your Labs
GLP-1 medications improve cholesterol, and the changes show up in ways that matter clinically. Patients on semaglutide and tirzepatide consistently see reductions in triglycerides,…
Can You Take Ozempic With a BMI Under 30: Eligibility Explained
Yes, it’s possible to get Ozempic or semaglutide with a BMI under 30, but the path looks different than it does for patients with…
GLP-1 Medications for Severe Obesity: What to Expect With a BMI Over 40
If your BMI is above 40, GLP-1 medications are among the most effective non-surgical tools available for weight loss. Clinical trials for both semaglutide…
How Ozempic Affects Your A1C: What to Expect and When
Ozempic lowers A1C, and it does so meaningfully. In clinical trials, semaglutide reduced A1C by an average of 1.5 to 2.0 percentage points, with…
Ozempic Weight Loss Plateau at Month 3: What to Do
A weight loss plateau around month three on Ozempic is common enough that it deserves its own explanation rather than being lumped into general…
